| De Rosa FG, Mollaretti O, Cometto C, et al.
Early experience with high-dosage daptomycin for prosthetic infections. [Comment, Letter]
Clin Infect Dis 2009 Dec 1; 49(11):1772-3.
Full Citation | Find Related Articles |
| Schutt AC, Bohm NM
Multidrug-Resistant Enterococcus faecium Endocarditis Treated with Combination Tigecycline and High-Dose Daptomycin (December). [JOURNAL ARTICLE]
Ann Pharmacother 2009 Nov 3.
Abstract | Full Citation |
| Sorlozano A, Gutierrez J, Martinez T, et al.
Detection of new mutations conferring resistance to linezolid in glycopeptide-intermediate susceptibility Staphylococcus hominis subspecies hominis circulating in an intensive care unit. [JOURNAL ARTICLE]
Eur J Clin Microbiol Infect Dis 2009 Oct 30.
Abstract | Full Citation |
| Sotto A, Laouini D, Bouziges N, et al.
[In vitro activity of daptomycin against strains isolated from diabetic foot ulcers.] [JOURNAL ARTICLE]
Pathol Biol (Paris) 2009 Oct 27.
Abstract | Full Citation |
| Mendes RE, Jones RN, Deshpande LM, et al.
Daptomycin Activity Tested Against Linezolid-Nonsusceptible Gram-Positive Clinical Isolates. [JOURNAL ARTICLE]
Microb Drug Resist 2009 Dec; 15(4):245-249.
Abstract | Full Citation | Find Related Articles |
| Croes S, Beisser PS, Terporten PH, et al.
Diminished in vitro antibacterial activity of oxacillin against clinical isolates of borderline oxacillin-resistant Staphylococcus aureus. [JOURNAL ARTICLE]
Clin Microbiol Infect 2009 Oct 22.
Abstract | Full Citation | Find Related Articles |
| Sakoulas G, Brown J, Lamp KC, et al.
Clinical outcomes of patients receiving daptomycin for the treatment of Staphylococcus aureus infections and assessment of clinical factors for daptomycin failure: A retrospective cohort study utilizing the Cubicin(R) Outcomes Registry and Experience. [Journal Article]
Clin Ther 2009 Sep; 31(9):1936-45.
Abstract | Full Citation | Find Related Articles |
| Adriaenssens N, Goossens H, Coenen S
Comment on: Developments in outpatient parenteral antimicrobial therapy (OPAT) for Gram-positive infections in Europe, and the potential impact of daptomycin. [JOURNAL ARTICLE]
J Antimicrob Chemother 2009 Oct 19.
Full Citation | Find Related Articles |
| Chen YH, Liu CY, Lu JJ, et al.
In vitro activity of nemonoxacin (TG-873870), a novel non-fluorinated quinolone, against clinical isolates of Staphylococcus aureus, enterococci and Streptococcus pneumoniae with various resistance phenotypes in Taiwan. [JOURNAL ARTICLE]
J Antimicrob Chemother 2009 Oct 14.
Abstract | Full Citation | Find Related Articles |
| Steenbergen JN, Mohr JF, Thorne GM
Effects of daptomycin in combination with other antimicrobial agents: a review of in vitro and animal model studies. [JOURNAL ARTICLE]
J Antimicrob Chemother 2009 Oct 12.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |
  |
